Immunowake

Developer of antibody-based therapeutics for the treatment of cancer

placeBirmingham, Alabama, United States calendar_todayFounded 2019 groups2 employees language immunowake.com

Innovation

7 patent families (3 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace steady. Cited 857 times.

YearFilings
20191
20201
20212
20224
20232
20243
20254

Investor mix

5 investors on record; lead investors include Hyfinity Investments.

Investor typeCountShare
Venture capital480%
Accelerator & incubator120%
Coming soon